The progression of prostate cancer is largely dependent on the activity of the androgen receptor (AR), which in turn, correlates with the net output of the AR transcriptional regulatory network.
A detailed and thorough understanding of the AR transcriptional regulatory network is therefore critical in the strategic manipulation of AR activity for the targeted eradication of prostate cancer cells. In this mini-review, we highlight some of the novel and unexpected mechanistic and functional insights of the AR transcriptional network derived from recent targeted sequencing (ChIP-Seq) studies of AR and its coregulatory factors in prostate cancer cells.
Written by:
Chng KR, Cheung E Are you the author?
Cancer Biology and Pharmacology, Genome Institute of Singapore, A(*)STAR (Agency for Science, Technology and Research), Singapore 138672, Singapore; Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 117573, Singapore
Reference: Cancer Lett. 2012 Nov 27. pii: S0304-3835(12)00656-8(Epub ahead of print)
doi: 10.1016/j.canlet.2012.11.009
PubMed Abstract
PMID: 23196061
